MedTrace Logo

High-Density Spinal Cord Stimulation for the Treatment of Chronic Intractable Pain Patients

NCT03318172 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-11-08

No results posted yet for this study

Summary

The purpose of this study is to explore which mode is effective in the management of intractable chronic pain, the high-density stimulation or the conventional stimulation, in patients who undergo SCS implantation after successful pre-implantation SCS trial.

Conditions

  • Pain, Intractable

Interventions

DEVICE

Spinal Cord Stimulator

Implantation of spinal cord stimulator in patients included in the study and divided in conventional and high density stimulation groups

Sponsors & Collaborators

  • Seoul National University

    lead OTHER

Principal Investigators

  • Jee Y Moon, PhD · Clinical Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-14
Primary Completion
2018-03-22
Completion
2018-04-12
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03318172 on ClinicalTrials.gov